How prepared are the US authorities for safe and expedient COVID-19 vaccine distribution?

As the US FDA advisory committee meets to discuss the merits of Pfizer/BioNTech’s application for emergency use of the company’s COVID-19 vaccine, we talk to two US legal experts to get their perspective on vaccine distribution stateside.